Utah Medical Products INC 10-Q quarterly reports

Utah Medical Products Inc. reported a 14.3% decrease in Q2 2026 sales and an 11.9% drop in net income compared to the same period in 2025, primarily due to the loss of two major customers.

Utah Medical Products Inc. reported a 10.2% decrease in Q1 2026 net sales compared to Q1 2025, primarily due to the loss of a major China distributor and lower international sales.

Utah Medical Products Inc. reported a significant drop in Q3 and nine-month net income and sales, primarily due to foreign trade events and distributor cancellations, leading to a revised full-year sales outlook.

Utah Medical Products reports a decline in Q2 and H1 2025 revenues and net income, primarily due to reduced sales to a major OEM customer and lower gross profit margins.

Utah Medical Products' Q1 2025 earnings decreased due to a significant drop in OEM sales, particularly to PendoTECH, despite growth in direct sales of NICU devices.

Utah Medical Products experienced a decrease in sales and earnings in the third quarter of 2024, primarily due to reduced OEM sales and Filshie Clip System sales, but maintained a strong balance sheet.

Utah Medical Products experienced a decrease in sales and earnings in the second quarter of 2024, primarily due to reduced demand from a major OEM customer and lower sales in key product categories.

Utah Medical Products experienced a decrease in sales and earnings for the first quarter of 2024, primarily due to reduced OEM sales and supply chain issues.